Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-009274
Filing Date
2017-02-09
Accepted
2017-02-09 19:21:34
Documents
1
Period of Report
2017-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8653
  Complete submission text file 0001209191-17-009274.txt   10023
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address FIVE PRIME THERAPEUTICS TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Belsky Marc (Reporting) CIK: 0001382629 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36070 | Film No.: 17589094